Apellis Pharmaceuticals, Inc.
CFO
7 appearances
Latest appearance 2025-09-30
Timothy Sullivan
CFO
Apellis Pharmaceuticals, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Timothy Sullivan
Timothy Sullivan is recorded as CFO at Apellis Pharmaceuticals, Inc.. The proxy statement of Apellis Pharmaceuticals, Inc. reports total compensation of $3,949,075 for Timothy Sullivan in fiscal 2024, including a base salary of $530,963. Disclosed compensation is on record for 8 fiscal years. Timothy Sullivan has spoken on 7 earnings calls across 1 company, most recently for Apellis Pharmaceuticals, Inc. on September 30, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Apellis Pharmaceuticals, Inc.
CFO
Source not stated
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Apellis Pharmaceuticals, Inc. | Chief Financial Officer | $530,963 | $3,949,075 |
| 2023 | Apellis Pharmaceuticals, Inc. | Chief Financial Officer | $496,654 | $3,737,235 |
| 2022 | Apellis Pharmaceuticals, Inc. | Chief Financial Officer | $469,093 | $3,546,148 |
| 2021 | Apellis Pharmaceuticals, Inc. | Chief Financial Officer | $452,692 | $3,075,916 |
| 2020 | Apellis Pharmaceuticals, Inc. | Chief Financial Officer | $430,269 | $3,485,149 |
| 2019 | Apellis Pharmaceuticals, Inc. | Chief Financial Officer | $386,423 | $1,719,303 |
| 2018 | Apellis Pharmaceuticals, Inc. | Chief Financial Officer | $380,000 | $859,752 |
| 2017 | Apellis Pharmaceuticals, Inc. | Chief Financial Officer | $68,939 | $2,296,699 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q3 FY2025 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q1 FY2024 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q3 FY2022 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q2 FY2022 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q1 FY2022 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q2 FY2021 Earnings Call
Apellis Pharmaceuticals, Inc.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q1 FY2021 Earnings Call
Apellis Pharmaceuticals, Inc.